Pediatric liver transplantation for metabolic liver disease: Experience at king's college hospital

Transplantation

Volumn 87, Issue 1, 2009, Pages 87-93

  Sze, Yuk K ^a   Dhawan, Anil ^a   Taylor, Rachel M ^a   Bansal, Sanjay ^a   Mieli Vergani, Giorgina ^a   Rela, Mohammed ^b   Heaton, Nigel ^b  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Children; Liver transplantation; Metabolic liver disease

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADOLESCENT; ARTICLE; CHILD; CHILD CARE; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER METABOLISM; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM; FIBROSIS; FOLLOW UP; HOSPITAL; INFANT; METABOLIC SYNDROME X; METABOLISM; NEWBORN; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GREAT BRITAIN; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; METABOLIC SYNDROME X; SURVIVAL RATE;

EID: 58949101340     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818bc0c4     Document Type: Article

References (40)

1. Murray KF, Carithers RL. AASLD practice guidelines: Evaluation ofthe patient for liver transplantation. Hepatology 2005; 41: 1407.
2. Otte JB, de Ville de GJ, Reding R, et al. Pediatric liver transplantation: From the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr Surg Int 1998; 13: 308.
3. BurdelskiM, NolkemperD,GanschowR, et al. Liver transplantation in children: Long-term outcome and quality of life. Eur J Pediatr 1999; 158(suppl 2): S34.
4. Jain A, Mazariegos G, Kashyap R, et al. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation 2002; 73: 941.
5. Martin SR, Atkison P, Anand R, et al. Studies of pediatric liver transplantation 2002: Patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant 2004; 8: 273.
6. Kayler LK, Merion RM, LeeS, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 2002; 6: 295.
7. Kayler LK, Rasmussen CS, Dykstra DM, et al. Liver transplantation in children with metabolic disordersin the United States. Am J Transplant 2003; 3: 334.
8. Morioka D, Kasahara M, Takada Y, et al. Living donor liver transplantation for pediatric patients with inheritable metabolic disorders. Am J Transplant 2005; 5: 2754.
9. Jaffe R. Liver transplant pathology in pediatric metabolic disorders. Pediatr Dev Pathol 1998; 1: 102.
10. Meyburg J, Hoffmann GF. Liver transplantation for inborn errors of metabolism. Transplantation 2005; 80(1 suppl): S135.
11. Nolkemper D, Kemper MJ, Burdelski M, et al. Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transplant 2000; 4: 177.
12. Shneider BL. Pediatric liver transplantation in metabolic disease: Clinical decision making. Pediatr Transplant 2002; 6: 25.
13. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000; 8: 1.
14. Prachalias AA, Kalife M, Francavilla R, et al. Liver transplantation for alpha-1-antitrypsin deficiency in children. Transpl Int 2000; 13: 207.
15. Rodrigues F, Kallas M, Nash R, et al. Neonatal hemochromatosis - Medical treatment vs. transplantation: The King's experience. Liver Transpl 2005; 11: 1417.
16. Bhattacharya N, Heaton N, Rela M, et al. The benefits of liver transplantation in glycogenosis type Ib. J Inherit Metab Dis 2004; 27: 539.
17. Matern D, Starzl TE, Arnaout W, et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 1999; 158(suppl 2): S43.
18. Morioka D, Takada Y, Kasahara M, et al. Living donor liver transplantation for non-cirrhotic inheritable metabolic liver diseases: Impact of the use of heterozygous donors. Transplantation 2005; 80: 623.
19. McDiarmid SV, Gornbein JA, DeSilva PJ, et al. Factors affecting growth after pediatric liver transplantation. Transplantation 1999; 67: 404.
20. Peeters PM, Sieders E, De Jong KP, et al. Comparison of outcome after pediatric liver transplantation for metabolic diseases and biliary atresia. Eur J Pediatr Surg 2001; 11: 28.
21. Schauer R, Stangl M, Lang T, et al. Treatment of Crigler-Najjar type 1 disease: Relevance of early liver transplantation. J Pediatr Surg 2003; 38: 1227.
22. Strauss KA, Mazariegos GV, Sindhi R, et al. Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transplant 2006; 6: 557.
23. Labrune P. Glycogen storage disease type I: Indications for liver and/or kidney transplantation. Eur J Pediatr 2002; 161(suppl 1): S53.
24. Jeong W, Rothberg PG, Delaney V, et al. Liver transplantation for type 1 primary hyperoxaluria as a cure for combined thrombophilia. Thromb Haemost 2004; 92: 1157.
25. Dujovne CA. Treatment of familial hypercholesterolemia and other genetic dyslipidemias. Curr Treat Options Cardiovasc Med 2004; 6: 269.
26. Pratschke J, Steinmuller T, Bechstein WO, et al. Orthotopic liver transplantation for hepatic associated metabolic disorders. Clin Transplant 1998; 12: 228.
27. Baliga P, Alvarez S, Lindblad A, et al. Post-transplant survival in pedi-atric fulminant hepatic failure: The SPLIT experience. Liver Transpl 2004; 10: 1364.
28. Farmer DG, Anselmo DM, Ghobrial RM, et al. Liver transplantation for fulminant hepatic failure: Experience with more than 200 patients over a 17-year period. Ann Surg 2003; 237: 666.
29. Goss JA, Shackleton CR, McDiarmid SV, et al. Long-term results of pediatric liver transplantation: An analysis of569 transplants. Ann Surg 1998; 228: 411.
30. Gustafsson BI, Backman L, Friman S, et al. Retransplantation of the liver. Transplant Proc 2006; 38: 1438.
31. Deshpande RR, Rela M, Girlanda R, et al. Long-term outcome of liver re-transplantation in children. Transplantation 2002; 74: 1124.
32. Jain A, Mazariegos G, Kashyap R, et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 2000; 70: 617.
33. Fisher RA, Strom SC. Human hepatocyte transplantation: Worldwide results. Transplantation 2006; 82: 441.
34. Rela M, Muiesan P, Vilca-Melendez H, et al. Auxiliary partial ortho-topic liver transplantation for Crigler-Najjar syndrome type I. Ann Surg 1999; 229: 565.
35. Fernandez-Miranda C,de LaCA, Morales JM, et al. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study. Clin Transplant 1998; 12: 136.
36. Scolapio JS, Bowen J, Lukens FJ, et al. Influence of tacrolimus and prednisone on serum lipids after liver transplantation. JPEN J Parenter Enteral Nutr 2001; 25: 148.
37. Shrotri M, Fernando BS, Sudhindran S, et al. Long-term outcome of liver transplantation for familial hypercholesterolemia. Transplant Proc 2003; 35: 381.
38. Alkofer BJ, Chiche L, Khayat A, et al. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: Report of the first case and review of the literature. Transplant Proc 2005; 37: 2250.
39. Kasahara M, Takada Y, Egawa H, et al. Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience. Am J Transplant 2005; 5: 558.
40. Azoulay D, Samuel D, Ichai P, et al. Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: A reappraisal from a single center by a case-control study. Ann Surg 2001; 234: 723.